Evidence mapPaperPMID 25644349Full record

Trial reportThe Journal of nutrition2015

Cholecalciferol supplementation does not influence β-cell function and insulin action in obese adolescents: a prospective double-blind randomized trial.

Asma Javed, Adrian Vella, P Babu Balagopal, Philip R Fischer, Amy L Weaver, Francesca Piccinini, Chiara Dalla Man, Claudio Cobelli, Paula D Giesler, Jeanette M Laugen and 1 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00858247 (Significance of Vitamin D Status in Obese Adolescents- A Pilot Study to Examine the Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00858247 phase2completednot on this map

Significance of Vitamin D Status in Obese Adolescents- A Pilot Study to Examine the Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors

TypeinterventionalSponsorMayo ClinicRan2009 to 2012Enrolled51ConditionsObesityArmsVitamin D3
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Vitamin D and Cardiovascular Risk: which Implications in Children?International journal of molecular sciences · 2020
    Review
  13. Article
  14. Review
  15. Review
  16. Vitamin D Supplementation In Obese Africian American Children.Journal of clinical & translational endocrinology · 2018
    Article
  17. Review
  18. Review
  19. Article
  20. An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State.Open access Macedonian journal of medical sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Asma JavedDivisions of Pediatric Endocrinology and.
Adrian VellaDivision of Endocrinology and Metabolism.
P Babu BalagopalNemours Children's Clinic, Research Division, Jacksonville, FL; and.
Philip R FischerGeneral Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine.
Amy L WeaverDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Francesca PiccininiInformation Engineering and.
Chiara Dalla ManDepartment of Electronics and Informatics, University of Padua, Padua, Italy.
Claudio CobelliDepartment of Electronics and Informatics, University of Padua, Padua, Italy.
Paula D GieslerEndocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, and.
Jeanette M LaugenEndocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, and.
Seema KumarDivisions of Pediatric Endocrinology and kumar.seema@mayo.edu.
Diabetes Australia · AUUniversity of Padua · ITMayo Clinic · USMayo Clinic in Arizona · USNemours Children’s Clinic · USOffice of Adolescent Health · USPediatrics and Genetics · US

Funding

The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · MAYO CLINIC ROCHESTER · 2025 to 2025
$667k
NCATS NIH HHS UL1 TR000135NIDDK NIH HHS R01 DK078646
6 · The paper itself

Abstract

backgroundThere is increasing interest in the extraskeletal effects of vitamin D, particularly in the obese state with regard to the development of insulin resistance and diabetes.

objectiveThe objective of the study was to determine the effect of 2 doses of cholecalciferol (vitamin D3) supplementation on insulin action (Si) and pancreatic β-cell function in obese adolescents.

methodsWe performed a 12-wk double-blind, randomized comparison of the effect of vitamin D3 supplementation on Si and β-cell function in obese Caucasian adolescents (body mass index > 95(th) percentile). The subjects were randomly assigned to receive either 400 IU/d (n = 25) or 2000 IU/d (n = 26) of vitamin D3. Each subject underwent a 7-sample 75 g oral glucose tolerance test, with glucose, insulin, and C-peptide measurements, to calculate Si and β-cell function as assessed by the disposition index (DI), with use of the oral minimal model before and after supplementation. A total of 51 subjects aged 15.0 ± 1.9 y were enrolled. Included for analysis at follow-up were a total of 46 subjects (20 male and 26 female adolescents), 23 in each group.

resultsInitial serum 25-hydroxyvitamin D [25(OH)D] was 24.0 ± 8.1 μg/L. There was no correlation between 25(OH)D concentrations and Si or DI. There was a modest but significant increase in 25(OH)D concentration in the 2000 IU/d group (3.1 ± 6.5 μg/L, P = 0.04) but not in the 400 IU/d group (P = 0.39). There was no change in Si or DI following vitamin D3 supplementation in either of the treatment groups (all P > 0.10).

conclusionsThe current study shows no effect from vitamin D3 supplementation, irrespective of its dose, on β-cell function or insulin action in obese nondiabetic adolescents with relatively good vitamin D status. Whether obese adolescents with vitamin D deficiency and impaired glucose metabolism would respond differently to vitamin D3 supplementation remains unclear and warrants further studies. This trial was registered at clinicaltrials.gov as NCT00858247.

Indexed as

Dietary SupplementsAdolescentBlood GlucoseBody Mass IndexChildCholecalciferolDouble-Blind MethodFemaleFollow-Up StudiesHealthy VolunteersHumansInsulinInsulin ResistanceInsulin-Secreting CellsMaleObesityBlood GlucoseCholecalciferolInsulinVitaminsdisposition indexinsulin actioninsulin secretionobese adolescentsvitamin D supplementation

Identifiers

PMID25644349
PMCPMC6619681
OpenAlexW2129122279

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.